ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Neuphoria Therapeutics Inc
4.05
-0.0200
-0.49%
盘后:
4.05
0.0000
0.00%
18:24 EST
成交量:
1.18万
成交额:
4.76万
市值:
2,177.82万
市盈率:
-1.01
高:
4.09
开:
3.99
低:
3.99
收:
4.07
52周最高:
21.40
52周最低:
3.65
股本:
537.73万
流通股本:
386.78万
量比:
0.73
换手率:
0.30%
股息:
- -
股息率:
- -
每股收益(TTM):
-4.0200
每股收益(LYR):
-0.2278
净资产收益率:
-64.04%
总资产收益率:
-7.25%
市净率:
1.74
市盈率(LYR):
-17.78
数据加载中...
总览
公司
新闻资讯
公告
知名代理顾问公司ISS建议股东使用白色代理卡为Neuphoria的两位董事提名人投票
美股速递
·
2025/12/08
Neuphoria Therapeutics Inc - 敦促股东在白色代理卡上投票支持Neuphoria的两名提名人
美股速递
·
2025/12/04
Neuphoria Therapeutics Inc - 暂停Bnc210在创伤后应激障碍方面的研发支出,并在公司战略评估中评估所有可能性
美股速递
·
2025/12/04
Lynx1 Capital Management向Neuphoria Therapeutics提出非约束性收购提议,报价为每股4.75美元现金
美股速递
·
2025/12/02
Lynx1 Capital Management Lp 于12月2日向Neuphoria Therapeutics董事会提交函件 - SEC备案
美股速递
·
2025/12/02
Lynx1 Capital Management Lp撤回收购Neuphoria Therapeutics的非约束性提议 - SEC备案
美股速递
·
2025/11/18
Neuphoria Therapeutics Inc - 可能不定期提供和销售高达2000万美元的普通股 - SEC文件
美股速递
·
2025/11/15
Neuphoria Therapeutics Inc - Lynx1 Master Fund在11月10日提供每股5.20美元现金收购Neuphoria
美股速递
·
2025/11/11
Neuphoria Therapeutics:确认收到Lynx1 Master Fund Lp的非正式投资意向及董事提名
美股速递
·
2025/11/11
Neuphoria Therapeutics Inc - 董事会宣布每股发行一项优先股购买权的股息
美股速递
·
2025/10/28
Neuphoria Therapeutics通过有限期限股东权利计划以保护过程的完整性
美股速递
·
2025/10/28
Neuphoria Therapeutics:可能不时提供和出售高达2190万美元的普通股 - SEC 备案
美股速递
·
2025/10/27
BUZZ--美国股票走势-Elevance、EPAM 系统、丹纳赫
路透中文
·
2025/10/21
BUZZ--美国股票走势-Elevance、EPAM 系统、丹纳赫
路透中文
·
2025/10/21
Neuphoria股价因试验失败暂停焦虑药物项目下跌65.8%至5.27美元
美股速递
·
2025/10/21
Neuphoria Therapeutics 股价在延长交易中下跌67.21%,报5.05美元;在第三阶段试验后停止焦虑药物的开发
美股速递
·
2025/10/21
BUZZ-试验失败迫使焦虑症药物项目停滞,Neuphoria 公司股价暴跌
路透中文
·
2025/10/21
Neuphoria Therapeutics更新Affirm-1三期试验进展,评估Bnc210治疗社交焦虑症急性发作
美股速递
·
2025/10/21
Neuphoria Therapeutics Inc在SAD治疗药物BNC-210的AFFIRM-1 III期试验中达成LPLV里程碑,预计第四季度公布顶线数据
美股速递
·
2025/09/30
美国研究综述-Chewy、Phillips 66、Vimeo
路透中文
·
2025/09/11
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/NEUP/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NEUP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NEUP\",,,,,undefined,":{"symbol":"NEUP","market":"US","secType":"STK","nameCN":"Neuphoria Therapeutics Inc","latestPrice":4.05,"timestamp":1771016400000,"preClose":4.07,"halted":0,"volume":11750,"hourTrading":{"tag":"盘后","latestPrice":4.05,"preClose":4.05,"latestTime":"18:24 EST","volume":2,"amount":8.149,"timestamp":1771025075667,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0049140049140050275,"floatShares":3867799,"shares":5377329,"eps":-4.02,"marketStatus":"总统日休市","change":-0.02,"latestTime":"02-13 16:00:00 EST","open":3.99,"high":4.09,"low":3.99,"amount":47598.550875,"amplitude":0.02457,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.02,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":4.07,"postHourTrading":{"tag":"盘后","latestPrice":4.05,"preClose":4.05,"latestTime":"18:24 EST","volume":2,"amount":8.149,"timestamp":1771025075667,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7283208272062414},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NEUP\",,,,,undefined,":{"symbol":"NEUP","floatShares":3867799,"roa":"-7.25%","roe":"-64.04%","lyrEps":-0.227756,"volumeRatio":0.7283208272062414,"shares":5377329,"dividePrice":0,"high":4.09,"amplitude":0.02457,"preClose":4.07,"low":3.99,"week52Low":3.645,"pbRate":"1.74","psRate":"1.39","week52High":21.4004,"institutionHeld":0.111,"latestPrice":4.05,"eps":-4.02,"divideRate":0,"volume":11750,"delay":0,"ttmEps":-4.02,"open":3.99,"prevYearClose":3.88,"prevWeekClose":4.05,"prevMonthClose":4.02,"prevQuarterClose":3.88,"fiveDayClose":4.01,"twentyDayClose":4.1,"sixtyDayClose":4.7},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NEUP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-14","symbol":"NEUP","fiscalQuarterEnding":"2025/09","expectedEps":-0.55,"name":null,"time":"盘后","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":-4.41},{"market":"US","date":"2025-09-29","symbol":"NEUP","fiscalQuarterEnding":"2025/06","expectedEps":-0.56,"name":null,"time":"盘后","type":"earning","dateTimestamp":1759118400000,"reportTimeType":"post","actualEps":-5.79},{"market":"US","date":"2024-12-24","symbol":"NEUP","defaultRemindTime":1735050600000,"type":"split","dateTimestamp":1735016400000,"forFactor":12,"toFactor":1,"ratio":12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NEUP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NEUP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.6667,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1761022800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NEUP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NEUP","date":"2026-02-13","current":-1.007463,"percent":0.229682,"low":-2152.911097,"twenty":-2.38113,"median":-1.071761,"eighty":2.312608,"high":4.870093,"avg":-36.428254,"sd":203.757581,"marketCap":21885729},"quantilePoints":[{"date":"2024-12-27","current":-1445.015744,"twenty":-2011.332026,"median":-1798.963421,"eighty":-1586.594815,"marketCap":15641406744},{"date":"2025-01-03","current":-951.437333,"twenty":-1445.015744,"median":-1245.311321,"eighty":-1113.798652,"marketCap":10298723991},{"date":"2025-01-10","current":-0.484092,"twenty":-1335.908938,"median":-1032.617992,"eighty":-0.531583,"marketCap":5240001},{"date":"2025-01-17","current":-0.452507,"twenty":-1207.318772,"median":-0.536694,"eighty":-0.48107,"marketCap":4898109},{"date":"2025-01-24","current":-0.524667,"twenty":-1141.075354,"median":-0.511137,"eighty":-0.48107,"marketCap":5679203},{"date":"2025-01-31","current":-0.81331,"twenty":-1016.381861,"median":-0.554735,"eighty":-0.482883,"marketCap":8803579},{"date":"2025-02-07","current":-0.757686,"twenty":-381.062919,"median":-0.702062,"eighty":-0.484985,"marketCap":8201486},{"date":"2025-02-14","current":-0.691539,"twenty":-0.803388,"median":-0.699056,"eighty":-0.486483,"marketCap":7485483},{"date":"2025-02-21","current":-1.080318,"twenty":-1.103422,"median":-0.706573,"eighty":-0.495533,"marketCap":8872986},{"date":"2025-02-28","current":-1.110267,"twenty":-1.105989,"median":-0.757686,"eighty":-0.509378,"marketCap":9118970},{"date":"2025-03-07","current":-1.180862,"twenty":-1.111551,"median":-0.770464,"eighty":-0.516549,"marketCap":9698789},{"date":"2025-03-14","current":-1.035394,"twenty":-1.111551,"median":-0.796773,"eighty":-0.529478,"marketCap":8504010},{"date":"2025-03-21","current":-1.108128,"twenty":-1.110267,"median":-1.022558,"eighty":-0.551126,"marketCap":9101399},{"date":"2025-03-28","current":-1.240761,"twenty":-1.1415,"median":-1.048229,"eighty":-0.607653,"marketCap":10190756},{"date":"2025-04-04","current":-1.210812,"twenty":-1.180862,"median":-1.055716,"eighty":-0.664779,"marketCap":9944772},{"date":"2025-04-11","current":-1.048229,"twenty":-1.179151,"median":-1.052508,"eighty":-0.679813,"marketCap":8609432},{"date":"2025-04-17","current":-1.093153,"twenty":-1.172305,"median":-1.056786,"eighty":-0.692441,"marketCap":8978407},{"date":"2025-04-25","current":-1.110267,"twenty":-1.154335,"median":-1.064274,"eighty":-0.697252,"marketCap":9118970},{"date":"2025-05-02","current":-1.069622,"twenty":-1.152624,"median":-1.071761,"eighty":-0.702663,"marketCap":8785135},{"date":"2025-05-09","current":-1.056786,"twenty":-1.146207,"median":-1.070692,"eighty":-0.70567,"marketCap":8679713},{"date":"2025-05-16","current":-1.014001,"twenty":-1.12567,"median":-1.069622,"eighty":-0.714089,"marketCap":8328307},{"date":"2025-05-23","current":1.878545,"twenty":-1.12567,"median":-1.066199,"eighty":-0.70567,"marketCap":10946278},{"date":"2025-05-30","current":2.090639,"twenty":-1.118824,"median":-1.058925,"eighty":-0.691539,"marketCap":12182153},{"date":"2025-06-06","current":2.306801,"twenty":-1.112407,"median":-1.056786,"eighty":-0.536694,"marketCap":13441728},{"date":"2025-06-13","current":2.303575,"twenty":-1.112407,"median":-1.053577,"eighty":-0.487084,"marketCap":13422928},{"date":"2025-06-20","current":2.135807,"twenty":-1.112407,"median":-1.052016,"eighty":-0.48107,"marketCap":12445348},{"date":"2025-06-27","current":2.193881,"twenty":-1.110695,"median":-1.048229,"eighty":-0.028511,"marketCap":12783741},{"date":"2025-07-03","current":2.300349,"twenty":-1.110267,"median":-1.04609,"eighty":1.971267,"marketCap":13404129},{"date":"2025-07-11","current":2.451984,"twenty":-1.110267,"median":-1.029511,"eighty":2.139033,"marketCap":14287711},{"date":"2025-07-18","current":2.416495,"twenty":-1.110267,"median":-1.009723,"eighty":2.183557,"marketCap":14080915},{"date":"2025-07-25","current":2.710088,"twenty":-1.108984,"median":-0.902959,"eighty":2.199559,"marketCap":15791680},{"date":"2025-08-01","current":2.616525,"twenty":-1.108128,"median":-0.783243,"eighty":2.258407,"marketCap":15246491},{"date":"2025-08-08","current":2.500379,"twenty":-1.107461,"median":-0.765954,"eighty":2.294542,"marketCap":14569705},{"date":"2025-08-15","current":2.613299,"twenty":-1.106066,"median":-0.738143,"eighty":2.306801,"marketCap":15227692},{"date":"2025-08-22","current":2.232596,"twenty":-1.104483,"median":-0.703565,"eighty":2.308091,"marketCap":13009337},{"date":"2025-08-29","current":3.939307,"twenty":-1.101283,"median":-0.691539,"eighty":2.322933,"marketCap":22954336},{"date":"2025-09-05","current":3.845744,"twenty":-1.099571,"median":-0.659969,"eighty":2.388052,"marketCap":22409147},{"date":"2025-09-12","current":4.513587,"twenty":-1.099503,"median":-0.53068,"eighty":2.412623,"marketCap":26300668},{"date":"2025-09-19","current":3.032718,"twenty":-1.096901,"median":-0.508206,"eighty":2.459921,"marketCap":17671642},{"date":"2025-09-26","current":4.016738,"twenty":-1.093153,"median":-0.484837,"eighty":2.484247,"marketCap":23405526},{"date":"2025-10-03","current":-93.377884,"twenty":-1.099571,"median":-0.487084,"eighty":2.484247,"marketCap":34515454},{"date":"2025-10-10","current":-121.187146,"twenty":-1.107683,"median":-0.517902,"eighty":2.484247,"marketCap":44794647},{"date":"2025-10-17","current":-96.758368,"twenty":-1.110267,"median":-0.572775,"eighty":2.482957,"marketCap":35764989},{"date":"2025-10-24","current":-25.831995,"twenty":-1.112407,"median":-0.681767,"eighty":2.474697,"marketCap":9548332},{"date":"2025-10-31","current":-28.064391,"twenty":-1.152196,"median":-0.702062,"eighty":2.459921,"marketCap":10373497},{"date":"2025-11-07","current":-27.298997,"twenty":-1.179151,"median":-0.72311,"eighty":2.450694,"marketCap":10090583},{"date":"2025-11-14","current":-30.296784,"twenty":-1.215946,"median":-0.765203,"eighty":2.444886,"marketCap":11198661},{"date":"2025-11-21","current":-2.390214,"twenty":-1.237338,"median":-0.778733,"eighty":2.430045,"marketCap":22638555},{"date":"2025-11-28","current":-2.566216,"twenty":-2.485596,"median":-0.805041,"eighty":2.414559,"marketCap":24305527},{"date":"2025-12-05","current":-2.424279,"twenty":-2.506035,"median":-0.994748,"eighty":2.406545,"marketCap":22961194},{"date":"2025-12-12","current":-2.259633,"twenty":-2.513983,"median":-1.018814,"eighty":2.405087,"marketCap":21401769},{"date":"2025-12-19","current":-2.208535,"twenty":-2.506035,"median":-1.043951,"eighty":2.402299,"marketCap":20917809},{"date":"2025-12-26","current":-2.151761,"twenty":-2.492409,"median":-1.048229,"eighty":2.397137,"marketCap":20380076},{"date":"2026-01-02","current":-2.202858,"twenty":-2.483325,"median":-1.048229,"eighty":2.378967,"marketCap":20864036},{"date":"2026-01-09","current":-2.31073,"twenty":-2.435634,"median":-1.052508,"eighty":2.369366,"marketCap":21885729},{"date":"2026-01-16","current":-2.327762,"twenty":-2.424279,"median":-1.055289,"eighty":2.331967,"marketCap":22047048},{"date":"2026-01-23","current":-2.367504,"twenty":-2.40384,"median":-1.056786,"eighty":2.322933,"marketCap":22423461},{"date":"2026-01-30","current":-2.282342,"twenty":-2.390214,"median":-1.06192,"eighty":2.319061,"marketCap":21616862},{"date":"2026-02-06","current":-2.268149,"twenty":-2.386808,"median":-1.069622,"eighty":2.31648,"marketCap":21482429},{"date":"2026-02-13","current":-2.31073,"twenty":-2.38113,"median":-1.071761,"eighty":2.312608,"marketCap":21885729}],"updateTime":1771242835909},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NEUP\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1186846363","title":"知名代理顾问公司ISS建议股东使用白色代理卡为Neuphoria的两位董事提名人投票","url":"https://stock-news.laohu8.com/highlight/detail?id=1186846363","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186846363?lang=zh_cn&edition=fundamental","pubTime":"2025-12-08 21:07","pubTimestamp":1765199235,"startTime":"0","endTime":"0","summary":"知名代理顾问公司ISS建议股东使用白色代理卡为Neuphoria的两位董事提名人投票","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NEUP"],"gpt_icon":0},{"id":"1178607496","title":"Neuphoria Therapeutics Inc - 敦促股东在白色代理卡上投票支持Neuphoria的两名提名人","url":"https://stock-news.laohu8.com/highlight/detail?id=1178607496","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178607496?lang=zh_cn&edition=fundamental","pubTime":"2025-12-04 21:05","pubTimestamp":1764853516,"startTime":"0","endTime":"0","summary":"Neuphoria Therapeutics Inc - 敦促股东在白色代理卡上投票支持Neuphoria的两名提名人","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEUP","BK4139"],"gpt_icon":0},{"id":"1164604292","title":"Neuphoria Therapeutics Inc - 暂停Bnc210在创伤后应激障碍方面的研发支出,并在公司战略评估中评估所有可能性","url":"https://stock-news.laohu8.com/highlight/detail?id=1164604292","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164604292?lang=zh_cn&edition=fundamental","pubTime":"2025-12-04 21:03","pubTimestamp":1764853402,"startTime":"0","endTime":"0","summary":"Neuphoria Therapeutics Inc - 暂停Bnc210在创伤后应激障碍方面的研发支出,并在公司战略评估中评估所有可能性","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NEUP"],"gpt_icon":0},{"id":"1127135911","title":"Lynx1 Capital Management向Neuphoria Therapeutics提出非约束性收购提议,报价为每股4.75美元现金","url":"https://stock-news.laohu8.com/highlight/detail?id=1127135911","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127135911?lang=zh_cn&edition=fundamental","pubTime":"2025-12-02 21:35","pubTimestamp":1764682510,"startTime":"0","endTime":"0","summary":"Lynx1 Capital Management向Neuphoria Therapeutics提出非约束性提议,计划以每股4.75美元的现金收购其所有流通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEUP","BK4139"],"gpt_icon":0},{"id":"1188165374","title":"Lynx1 Capital Management Lp 于12月2日向Neuphoria Therapeutics董事会提交函件 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1188165374","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188165374?lang=zh_cn&edition=fundamental","pubTime":"2025-12-02 21:32","pubTimestamp":1764682337,"startTime":"0","endTime":"0","summary":"Lynx1 Capital Management Lp 于12月2日向Neuphoria Therapeutics董事会提交函件 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEUP","BK4139"],"gpt_icon":0},{"id":"1125692194","title":"Lynx1 Capital Management Lp撤回收购Neuphoria Therapeutics的非约束性提议 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1125692194","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125692194?lang=zh_cn&edition=fundamental","pubTime":"2025-11-18 21:38","pubTimestamp":1763473129,"startTime":"0","endTime":"0","summary":"Lynx1 Capital Management Lp撤回了此前提出的收购Neuphoria Therapeutics的非约束性提议,并已在SEC备案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NEUP"],"gpt_icon":0},{"id":"1138335047","title":"Neuphoria Therapeutics Inc - 可能不定期提供和销售高达2000万美元的普通股 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1138335047","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138335047?lang=zh_cn&edition=fundamental","pubTime":"2025-11-15 05:25","pubTimestamp":1763155509,"startTime":"0","endTime":"0","summary":"Neuphoria Therapeutics Inc - 可能不定期提供和销售高达2000万美元的普通股 - SEC文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NEUP"],"gpt_icon":0},{"id":"1143200172","title":"Neuphoria Therapeutics Inc - Lynx1 Master Fund在11月10日提供每股5.20美元现金收购Neuphoria","url":"https://stock-news.laohu8.com/highlight/detail?id=1143200172","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143200172?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 20:02","pubTimestamp":1762862533,"startTime":"0","endTime":"0","summary":"Neuphoria Therapeutics Inc - Lynx1 Master Fund在11月10日提供每股5.20美元现金收购Neuphoria","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NEUP"],"gpt_icon":0},{"id":"1162850350","title":"Neuphoria Therapeutics:确认收到Lynx1 Master Fund Lp的非正式投资意向及董事提名","url":"https://stock-news.laohu8.com/highlight/detail?id=1162850350","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162850350?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 20:01","pubTimestamp":1762862483,"startTime":"0","endTime":"0","summary":"Neuphoria Therapeutics:确认收到Lynx1 Master Fund Lp的非正式投资意向及董事提名","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NEUP"],"gpt_icon":0},{"id":"1154437346","title":"Neuphoria Therapeutics Inc - 董事会宣布每股发行一项优先股购买权的股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1154437346","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154437346?lang=zh_cn&edition=fundamental","pubTime":"2025-10-28 04:30","pubTimestamp":1761597014,"startTime":"0","endTime":"0","summary":"Neuphoria Therapeutics Inc - 董事会宣布每股发行一项优先股购买权的股息","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NEUP"],"gpt_icon":0},{"id":"1105322519","title":"Neuphoria Therapeutics通过有限期限股东权利计划以保护过程的完整性","url":"https://stock-news.laohu8.com/highlight/detail?id=1105322519","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105322519?lang=zh_cn&edition=fundamental","pubTime":"2025-10-28 04:30","pubTimestamp":1761597014,"startTime":"0","endTime":"0","summary":"Neuphoria Therapeutics通过有限期限股东权利计划以保护过程的完整性","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEUP","BK4139"],"gpt_icon":0},{"id":"1151086403","title":"Neuphoria Therapeutics:可能不时提供和出售高达2190万美元的普通股 - SEC 备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1151086403","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151086403?lang=zh_cn&edition=fundamental","pubTime":"2025-10-27 21:45","pubTimestamp":1761572715,"startTime":"0","endTime":"0","summary":"Neuphoria Therapeutics:可能不时提供和出售高达2190万美元的普通股 - SEC 备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEUP","BK4139"],"gpt_icon":0},{"id":"2577822438","title":"BUZZ--美国股票走势-Elevance、EPAM 系统、丹纳赫","url":"https://stock-news.laohu8.com/highlight/detail?id=2577822438","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577822438?lang=zh_cn&edition=fundamental","pubTime":"2025-10-21 19:39","pubTimestamp":1761046762,"startTime":"0","endTime":"0","summary":"** Galapagos NV GLPG.O:BUZZ - CAR T宣布关闭业务后,股价创下近五年来最差表现。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nL4T3W20SO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2045819591.USD","CNC","EPAM","HAL","LU2168564495.EUR","LU2168564065.EUR","IE00BSNM7G36.USD","GM","MMM","CVS","GE","LU2168564222.USD","LU1670711040.USD","LU0122379950.USD","LU0965509101.SGD","BK4504","SGXZ99366536.SGD","ELV","BK4129","DGX","LU1061106388.HKD","LU1267930490.SGD","LU2106854487.HKD","ZION","SGXZ51526630.SGD","LU2125910500.SGD","LU0312595415.SGD","LU1506573853.SGD","LU0106261372.USD","NEUP","RTX","BK4566","LU1670627923.USD","IE0002270589.USD","LU0912757837.SGD","HUM","PM","UHS","WRB","SG9999018857.SGD","BK4206","LU1323610961.USD","NEM","FLR","IRDM","DHR","IE00B7SZLL34.SGD"],"gpt_icon":1},{"id":"2577224808","title":"BUZZ--美国股票走势-Elevance、EPAM 系统、丹纳赫","url":"https://stock-news.laohu8.com/highlight/detail?id=2577224808","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577224808?lang=zh_cn&edition=fundamental","pubTime":"2025-10-21 19:39","pubTimestamp":1761046762,"startTime":"0","endTime":"0","summary":"** Galapagos NV GLPG.O:BUZZ - CAR T宣布关闭业务后,股价创下近五年来最差表现。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nL4S3W20SO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVS","LU0096364046.USD","ZION","ELV","LU0426417589.USD","FLR","NEM","LU0456854461.SGD","LU0187121727.USD","HAL","LU0861579265.USD","LU0208291251.USD","LU1883866441.USD","LU0029864427.USD","BK4154","GM","RTX","LU0795875086.SGD","LU0278409577.USD","CNC","LU0820562030.AUD","PM","LU0300736062.USD","BK4564","MMM","WRB","IRDM","UHS","LU0354030511.USD","IE00BFSS7M15.SGD","LU1023059493.AUD","DGX","LU0943347566.SGD","HUM","LU1223082196.USD","LU0048573561.USD","LU0511384066.AUD","LU0882574055.USD","BK4501","GE","LU0300736492.USD","IE00B19Z8X17.USD","NEUP","DHR","LU2552382132.HKD","LU1223083913.SGD","EPAM"],"gpt_icon":1},{"id":"1137881661","title":"Neuphoria股价因试验失败暂停焦虑药物项目下跌65.8%至5.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1137881661","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137881661?lang=zh_cn&edition=fundamental","pubTime":"2025-10-21 16:29","pubTimestamp":1761035350,"startTime":"0","endTime":"0","summary":"Neuphoria股价因试验失败导致焦虑药物项目暂停,盘前下跌65.8%,报5.27美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NEUP"],"gpt_icon":0},{"id":"1179026626","title":"Neuphoria Therapeutics 股价在延长交易中下跌67.21%,报5.05美元;在第三阶段试验后停止焦虑药物的开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1179026626","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179026626?lang=zh_cn&edition=fundamental","pubTime":"2025-10-21 05:39","pubTimestamp":1760996350,"startTime":"0","endTime":"0","summary":"Neuphoria Therapeutics 股价在延长交易中下跌67.21%,报5.05美元;在第三阶段试验后停止焦虑药物的开发。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEUP","BK4139"],"gpt_icon":0},{"id":"2577896301","title":"BUZZ-试验失败迫使焦虑症药物项目停滞,Neuphoria 公司股价暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2577896301","media":"路透中文","labels":["productRelease","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577896301?lang=zh_cn&edition=fundamental","pubTime":"2025-10-21 05:11","pubTimestamp":1760994685,"startTime":"0","endTime":"0","summary":"BUZZ-试验失败迫使焦虑症药物项目停滞,Neuphoria 公司股价暴跌10月20日 - ** 药物开发商Neuphoria Therapeutics NEUP.O股价在延时交易中下跌72%,至4.30美元** 该公司称,其治疗社交焦虑症的实验性药物在一项后期试验中未能 ,因此NEUP停止了该项目的开发。** 该公司正在社交焦虑症患者中测试 BNC210 药物,但该药物并未达到其主要目标,即减少公众演讲挑战中的痛苦。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nL4S3W10XF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"BUZZ-试验失败迫使焦虑症药物项目停滞,Neuphoria 公司股价暴跌","news_tag":"productRelease,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NEUP"],"gpt_icon":0},{"id":"1102819182","title":"Neuphoria Therapeutics更新Affirm-1三期试验进展,评估Bnc210治疗社交焦虑症急性发作","url":"https://stock-news.laohu8.com/highlight/detail?id=1102819182","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102819182?lang=zh_cn&edition=fundamental","pubTime":"2025-10-21 04:16","pubTimestamp":1760991368,"startTime":"0","endTime":"0","summary":"Neuphoria Therapeutics更新Affirm-1三期试验进展,评估Bnc210治疗社交焦虑症急性发作","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEUP","BK4139"],"gpt_icon":0},{"id":"1192631265","title":"Neuphoria Therapeutics Inc在SAD治疗药物BNC-210的AFFIRM-1 III期试验中达成LPLV里程碑,预计第四季度公布顶线数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1192631265","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192631265?lang=zh_cn&edition=fundamental","pubTime":"2025-09-30 04:57","pubTimestamp":1759179434,"startTime":"0","endTime":"0","summary":"Neuphoria Therapeutics Inc在其BNC-210治疗季节性情感障碍(SAD)的AFFIRM-1 III期试验中成功达成LPLV里程碑,预计将在第四季度公布顶线研究结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NEUP"],"gpt_icon":0},{"id":"2566952752","title":"美国研究综述-Chewy、Phillips 66、Vimeo","url":"https://stock-news.laohu8.com/highlight/detail?id=2566952752","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566952752?lang=zh_cn&edition=fundamental","pubTime":"2025-09-11 15:57","pubTimestamp":1757577462,"startTime":"0","endTime":"0","summary":"美国研究综述-Chewy、Phillips 66、Vimeo路透社9月11日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价,其中包括 Chewy、Phillips 66 和 Vimeo。要闻* Chewy公司CHWY.N:摩根大通将目标价从47美元下调至45美元 * Phillips 66 PSX.N:Piper Sandler将目标价从144美元上调至154美元 * Vimeo Inc VMEO.O:Piper Sandler将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nL3T3UY0HY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAMP","LU0266512127.USD","MPC","BK4221","DK","LU0310800965.SGD","CASY","LU0368265418.SGD","LU1169590202.USD","MNSH","PBF","LU0566484027.USD","BK4139","LU0208291251.USD","LU1267930227.SGD","IE0009354923.USD","IE00B2Q91V27.USD","WY","BK4138","LU0980610538.SGD","BK4084","BK4113","DINO","LU0345780950.USD","TPR","IE00BGHQF524.EUR","CHWY","RBRK","PSX","BK4202","LU0130517989.USD","LU0757428866.USD","LU1941712348.USD","PARR","LU1169589451.USD","BK4023","LU1559883803.SGD","IE00B3T34201.USD","FROG","VMEO","LU1941712264.USD","WK","IE00B3CCJ963.GBP","LU0130102774.USD","RAPP","BK4585","NEUP","BK4200","VLO"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}]}}